这篇文章不错，转发给_老虎社区_美港股上老虎

这篇文章不错，转发给大家看看

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":373760361566320,"tweetId":"373760361566320","gmtCreate":1732287514803,"gmtModify":1732287516388,"author":{"id":4175171705858830,"idStr":"4175171705858830","authorId":4175171705858830,"authorIdStr":"4175171705858830","name":"海容易啊","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":0,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"html":"<html><head></head><body>这篇文章不错，转发给大家看看</body></html>","htmlText":"<html><head></head><body>这篇文章不错，转发给大家看看</body></html>","text":"这篇文章不错，转发给大家看看","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/373760361566320","repostId":1183551855,"repostType":4,"repost":{"id":"1183551855","pubTimestamp":1732181469,"share":"https://www.laohu8.com/m/news/1183551855?lang=&edition=full","pubTime":"2024-11-21 17:31","market":"us","language":"zh","title":"基于癌症和炎症药物乐观前景，诺华上调中期销售预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1183551855","media":"智通财经网","summary":"公司营收将以每年6%的速度增长。","content":"<html><head></head><body><p>基于对新的癌症和免疫疾病药物以及神经和心血管疾病治疗药物的乐观预期，诺华上调了中期销售预期。这家总部位于瑞士巴塞尔的制药商周四表示，到2029年，公司营收将以每年6%的速度增长，高于此前5%的预期。诺华上调了对其旗下药物Cosentyx、Kisqali、Kesimpta、Pluvicto和Leqvio的峰值销售预期，其中多数药物预计将在本世纪30年代或更晚获得美国独家经营权。</p><p style=\"text-align: justify;\">首席执行官Vas Narasimhan强调，“未来几年将有超过15项可提交数据，以进一步促进我们的增长。”</p><p style=\"text-align: justify;\">诺华还表示，该公司还有30多个其他正在开发的资产，这些资产将在2029年之后实现4%-6%的增长。</p><p style=\"text-align: justify;\">该集团在削减了曾经庞大的医疗保健业务组合后，正在推动增长，以专注于创新药物。一年前，随着仿制药生产商Sandoz的分拆，Narasimhan完成了转型的最后一个重要步骤。</p><p style=\"text-align: justify;\">该公司股价今年以来上涨了7.2%，而彭博追踪欧洲制药公司的指数仅上涨了3.1%。</p><p></p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/89f0c28655b8f07f1a56098d5c337a83\" tg-width=\"560\" tg-height=\"240\"/></p><p></p></body></html>","source":"stock_zhitongcaijing","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>基于癌症和炎症药物乐观前景，诺华上调中期销售预期</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n基于癌症和炎症药物乐观前景，诺华上调中期销售预期\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-21 17:31 北京时间&nbsp;&nbsp;&nbsp;<a href=https://www.zhitongcaijing.com/content/detail/1214014.html><strong>智通财经网</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>基于对新的癌症和免疫疾病药物以及神经和心血管疾病治疗药物的乐观预期，诺华上调了中期销售预期。这家总部位于瑞士巴塞尔的制药商周四表示，到2029年，公司营收将以每年6%的速度增长，高于此前5%的预期。诺华上调了对其旗下药物Cosentyx、Kisqali、Kesimpta、Pluvicto和Leqvio的峰值销售预期，其中多数药物预计将在本世纪30年代或更晚获得美国独家经营权。首席执行官Vas ...</p>\n\n<a href=\"https://www.zhitongcaijing.com/content/detail/1214014.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/7766c80d5c26c9599970478e92d8da00","relate_stocks":{"NVS":"诺华"},"source_url":"https://www.zhitongcaijing.com/content/detail/1214014.html","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1183551855","content_text":"基于对新的癌症和免疫疾病药物以及神经和心血管疾病治疗药物的乐观预期，诺华上调了中期销售预期。这家总部位于瑞士巴塞尔的制药商周四表示，到2029年，公司营收将以每年6%的速度增长，高于此前5%的预期。诺华上调了对其旗下药物Cosentyx、Kisqali、Kesimpta、Pluvicto和Leqvio的峰值销售预期，其中多数药物预计将在本世纪30年代或更晚获得美国独家经营权。首席执行官Vas Narasimhan强调，“未来几年将有超过15项可提交数据，以进一步促进我们的增长。”诺华还表示，该公司还有30多个其他正在开发的资产，这些资产将在2029年之后实现4%-6%的增长。该集团在削减了曾经庞大的医疗保健业务组合后，正在推动增长，以专注于创新药物。一年前，随着仿制药生产商Sandoz的分拆，Narasimhan完成了转型的最后一个重要步骤。该公司股价今年以来上涨了7.2%，而彭博追踪欧洲制药公司的指数仅上涨了3.1%。","news_type":1},"isVote":1,"tweetType":1,"viewCount":1,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":27,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/373760361566320"}